Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Subcutaneously Administered Natural Progesterone for the Treatment of Recurrent GBM

NCT05091866 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05091866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05091866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Subcutaneously Administered Natural Progesterone for the Treatment of Recurrent GBM
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Terminated
Start date
April 11, 2022
Completion date
March 9, 2026
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gliosarcoma, recurrent glioblastoma